Cargando…
Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial)
BACKGROUND: It is a continuous matter of discussion whether immune activation by vaccination in general and Influenza vaccination in particular increases the risk for clinical deterioration of autoimmune diseases. This prospective study investigated the serological and clinical course of autoimmune...
Autores principales: | Tackenberg, Björn, Schneider, Maximilian, Blaes, Franz, Eienbröker, Christian, Schade-Brittinger, Carmen, Wellek, Anne, Deschauer, Marcus, Eickmann, Markus, Klenk, Hans-Dieter, Müller, Hans-Helge, Sommer, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835557/ https://www.ncbi.nlm.nih.gov/pubmed/29337134 http://dx.doi.org/10.1016/j.ebiom.2018.01.007 |
Ejemplares similares
-
Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis
por: Ayzenberg, Ilya, et al.
Publicado: (2019) -
Myasthenia Gravis: Analysis of Serum Autoantibody Reactivities to 1827 Potential Human Autoantigens by Protein Macroarrays
por: Becker, Anne, et al.
Publicado: (2013) -
Significance of Acetylcholine Receptor Antibody Titers in Acetylcholine Receptor Antibody-Positive Ocular Myasthenia Gravis: Generalization and Presence of Thyroid Autoimmune Antibodies and Thymoma
por: Supawongwattana, Montana, et al.
Publicado: (2023) -
Prominent T-Cell Responses against the Acetylcholine Receptor ε Subunit in Myasthenia Gravis
por: Neuhaus, Oliver, et al.
Publicado: (2019) -
Clinical trials in myasthenia gravis
por: Mahmood, A., et al.
Publicado: (2023)